Sentences with phrase «of ovarian cancer patients»

Together, these and other findings strongly suggest that immunotherapies that can induce or enhance optimal immunologic conditions within ovarian cancers may hold great promise for extending the lives of ovarian cancer patients.

They even found talcum powder particles in the tumors of the ovarian cancer patients they studied.

The newly approved drug would target about 15 to 20 percent of ovarian cancer patients who have the specific gene mutation, known as deleterious BRCA.

By evaluating the molecular changes that occur in large cohorts of ovarian cancer patients, the researchers were able to identify several lncRNAs that are linked to the disease.

Its authors point out that in 60 to 85 per cent of ovarian cancer patients, relapse will occur after initial treatment.

«Niraparib significantly improves outcome of ovarian cancer patients in landmark trial.»

Notably, the researchers found that, using their methods, highly reactive TILs could be obtained from some 90 % of the ovarian cancer patients whose tumor samples they examined.

The clinical course of ovarian cancer patients is marked by periods of remission and relapse of sequentially shortening duration until chemotherapy resistance develops.

Hopefully that will approximate cures or will greatly extend the survival of ovarian cancer patients.

«Our study suggests a therapeutic benefit for repurposing a well - tolerated inhibitor with limited toxicity to treat a specific group of ovarian cancer patients with high levels of CARM1 expression,» said Sergey Karakashev, Ph.D., first author of the study and a postdoctoral researcher in the Zhang Lab.

I am dedicated to making a significant difference in the lives of ovarian cancer patients and I believe this to be a critical step.»

«The current options for maintenance therapy in the EU are bevacizumab, which can only be given once and improves progression - free survival by just a few months, and the PARP inhibitor olaparib, which is only approved in patients with a germline BRCA mutation (about 10 - 15 % of ovarian cancer patients).

Niraparib significantly improved all endpoints across a broad patient population representing 70 % of all ovarian cancer patients.

In the proposed project, Dr. Lampi Hermanson will produce NK cells from stem cells, inserting a chimeric antigen receptor (CAR) with the capacity to recognize mesothelin cells, which is expressed in 70 % of ovarian cancer patients.

[pagebreak] Chemo is getting better Between 70 and 90 % of ovarian cancer patients have a recurrence.